Literature DB >> 14963138

Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious.

Feng Gao1, Yalu Chen, David N Levy, Joan A Conway, Thomas B Kepler, Huxiong Hui.   

Abstract

Mutation rates of human immunodeficiency virus type 1 (HIV-1) genomes have been estimated using purified reverse transcriptase or single-round infection system. Since small sequences were used as templates, the overall mutation rates could only be extrapolated and the biological significance of mutations is unknown. For direct estimation of HIV-1 mutation rates and understanding of the potential biological influences of mutations, we obtained 19 complete or nearly full-length proviral genomes from single-round-infected adherent cells of lymphocytes by using a lambda phage library method and a long-range PCR technique. Analysis of 160,000 bp of sequences showed that the overall mutation rate of HIV-1 genomes was 5.4 x 10(-5) per base per replication cycle. On average, 1.1 mutations (range, 0 to 3) were generated in each viral genome during one infection cycle. Inspection of the mutations in the HIV-1 genome revealed that all site mutations within protein-coding regions were nonsynonymous mutations. Among all mutations, half were deleterious (premature stop codon and deletions) and would result in defective genomes. By applying the same system to an HIV-1 genome with a G262A mutation in the thumb region of the reverse transcriptase, a significant increase was observed in deletion and insertion mutation rates but no increase in the overall mutation rate in viral genomes was found.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963138      PMCID: PMC369203          DOI: 10.1128/jvi.78.5.2426-2433.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Copy-choice recombination by reverse transcriptases: reshuffling of genetic markers mediated by RNA chaperones.

Authors:  M Negroni; H Buc
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Rates of spontaneous mutation among RNA viruses.

Authors:  J W Drake
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

3.  Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

Authors:  A Jacobo-Molina; J Ding; R G Nanni; A D Clark; X Lu; C Tantillo; R L Williams; G Kamer; A L Ferris; P Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Induction of cell differentiation by human immunodeficiency virus 1 vpr.

Authors:  D N Levy; L S Fernandes; W V Williams; D B Weiner
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

5.  Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

6.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

7.  Fidelity of HIV-1 reverse transcriptase copying a hypervariable region of the HIV-1 env gene.

Authors:  J Ji; L A Loeb
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

8.  The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag gene.

Authors:  L M Mansky; A E Krueger; H M Temin
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

9.  Viral dynamics in human immunodeficiency virus type 1 infection.

Authors:  X Wei; S K Ghosh; M E Taylor; V A Johnson; E A Emini; P Deutsch; J D Lifson; S Bonhoeffer; M A Nowak; B H Hahn
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

10.  Structure/function studies of human immunodeficiency virus type 1 reverse transcriptase. Alanine scanning mutagenesis of an alpha-helix in the thumb subdomain.

Authors:  W A Beard; S J Stahl; H R Kim; K Bebenek; A Kumar; M P Strub; S P Becerra; T A Kunkel; S H Wilson
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

View more
  24 in total

Review 1.  Viral mutation rates.

Authors:  Rafael Sanjuán; Miguel R Nebot; Nicola Chirico; Louis M Mansky; Robert Belshaw
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

2.  Constraints on HIV-1 diversity from protein structure.

Authors:  Jeongmin Woo; David L Robertson; Simon C Lovell
Journal:  J Virol       Date:  2010-09-29       Impact factor: 5.103

3.  5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors.

Authors:  Jonathan M Rawson; Richard H Heineman; Lauren B Beach; Jessica L Martin; Erica K Schnettler; Michael J Dapp; Steven E Patterson; Louis M Mansky
Journal:  Bioorg Med Chem       Date:  2013-08-20       Impact factor: 3.641

4.  Female genital tract shedding of CXCR4-tropic HIV Type 1 is associated with a majority population of CXCR4-tropic HIV Type 1 in blood and declining CD4(+) cell counts.

Authors:  Richard E Haaland; Sharon T Sullivan; Tammy Evans-Strickfaden; Jeffrey L Lennox; Clyde E Hart
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-23       Impact factor: 2.205

Review 5.  Polyvalent AIDS vaccines.

Authors:  Shan Lu; Jill M Grimes Serrano; Shixia Wang
Journal:  Curr HIV Res       Date:  2010-12       Impact factor: 1.581

6.  Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status.

Authors:  Sharon T Sullivan; Usha Mandava; Tammy Evans-Strickfaden; Jeffrey L Lennox; Tedd V Ellerbrock; Clyde E Hart
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 7.  Modeling sequence evolution in acute HIV-1 infection.

Authors:  Ha Youn Lee; Elena E Giorgi; Brandon F Keele; Brian Gaschen; Gayathri S Athreya; Jesus F Salazar-Gonzalez; Kimmy T Pham; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Beatrice H Hahn; George M Shaw; Bette T Korber; Tanmoy Bhattacharya; Alan S Perelson
Journal:  J Theor Biol       Date:  2009-08-04       Impact factor: 2.691

Review 8.  Lethal mutagenesis: targeting the mutator phenotype in cancer.

Authors:  Edward J Fox; Lawrence A Loeb
Journal:  Semin Cancer Biol       Date:  2010-10-08       Impact factor: 15.707

9.  Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.

Authors:  Andrew E Armitage; Koen Deforche; John J Welch; Kristel Van Laethem; Ricardo Camacho; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

10.  Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.

Authors:  Hongshuo Song; Jeffrey W Pavlicek; Fangping Cai; Tanmoy Bhattacharya; Hui Li; Shilpa S Iyer; Katharine J Bar; Julie M Decker; Nilu Goonetilleke; Michael K P Liu; Anna Berg; Bhavna Hora; Mark S Drinker; Josh Eudailey; Joy Pickeral; M Anthony Moody; Guido Ferrari; Andrew McMichael; Alan S Perelson; George M Shaw; Beatrice H Hahn; Barton F Haynes; Feng Gao
Journal:  Retrovirology       Date:  2012-10-30       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.